Cadrenal Therapeutics Inc. (CVKD) - סך הכנסות החברה

Cadrenal Therapeutics (CVKD) delegates production and testing to external partners, confirming the sales agility of the company, whose current chart on GURU.Markets contains 0.00, which forms the current metric indicator. The absence of revenue and dependence on capital create risks; however, the development of a unique anticoagulant for renal patients provides potential for a technological breakthrough in thrombosis therapy.
פילוחי מדדים מקיפים ואנליטיקה עבור Cadrenal Therapeutics (CVKD)

Cadrenal Therapeutics (CVKD) focuses on the development of anticoagulants without maintaining its own production facilities, which renders revenue dependent on clinical trial stages. The algorithm aggregates all actual daily cash inflows from sales, excluding speculative expectations. This metric allows for an objective assessment of the commercialization pace of biotechnological products and their market demand. By analyzing the volume of the company's sold products, an investor can compare current financial success with long-term development plans.